This is part of the ‘Health Academy Short Course’ series and provides clinicians with specific information related to the Zostavax vaccine.
This course is suitable for all Registered Healthcare Professionals, including Nurses, Pharmacists and GPs that administer this vaccine in practice.
This ‘Short Course’ will take approximately 30 minutes to complete.
The course will cover key details of the vaccine and the diseases that it protects against.
What ZOSTAVAX is and what it is used for
ZOSTAVAX is a vaccine used to prevent shingles (zoster) and zoster-related post-herpetic neuralgia
(PHN), the long-lasting nerve pain that follows shingles.
ZOSTAVAX is used to vaccinate individuals 50 years of age or older.
ZOSTAVAX cannot be used to treat existing shingles or the pain associated with existing shingles.
Disease information on shingles:
What is shingles?
Shingles is a painful, blistering rash. It usually occurs in one part of the body and can last for several
weeks. It may lead to severe and long-lasting pain and scarring. Less commonly, bacterial skin
infections, weakness, muscle paralysis, loss of hearing or vision can occur. Shingles is caused by the
same virus that causes chickenpox. After you have had chickenpox, the virus that caused it stays in
your body in nerve cells. Sometimes, after many years, the virus becomes active again and causes
What is PHN?
After the shingles blisters heal, pain can last for months or years and may be severe. This long-lasting
nerve pain is called post-herpetic neuralgia or PHN.